Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States

被引：0

作者：

Bernstein, Elana ^{[1
]}

VanBuren, John ^{[2
]}

Assassi, Shervin ^{[3
]}

Castelino, Flavia ^{[4
]}

Chung, Lorinda ^{[5
]}

Correia, Chase ^{[6
]}

Evnin, Luke ^{[7
]}

Frech, Tracy ^{[2
]}

Startup, Emily ^{[2
]}

Gordon, Jessica ^{[8
]}

Hant, Faye ^{[9
]}

Hummers, Laura ^{[10
]}

Sandorfi, Nora ^{[11
]}

Shah, Ami ^{[12
]}

Shanmugam, Victoria ^{[13
]}

Steen, Virginia ^{[14
]}

Khanna, Dinesh ^{[15
]}

机构：

[1] Columbia Univ, New York, NY USA

[2] Univ Utah, Salt Lake City, UT USA

[3] Univ Texas Houston, McGovern Med Sch Houston, Houston, TX USA

[4] Massachusetts Gen Hosp, Boston, MA 02114 USA

[5] Stanford Univ, Palo Alto, CA 94304 USA

[6] Northwestern Univ, Chicago, IL 60611 USA

[7] Scleroderma Res Fdn, Brisbane, CA USA

[8] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA

[9] Med Univ South Carolina, Charleston, SC 29425 USA

[10] Johns Hopkins Univ, Baltimore, MD USA

[11] Univ Penn, Philadelphia, PA 19104 USA

[12] Johns Hopkins Rheumatol, Baltimore, MD USA

[13] George Washington Univ, Great Falls, VA USA

[14] Georgetown Univ, Div Rheumatol, Washington, DC USA

[15] Univ Michigan, Ann Arbor, MI 48109 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0389

引用

页码：795 / 798

页数：4

共 50 条

[1] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
Yamasaki, Yoshioki
Kuwana, Masataka
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
[2] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Moran-Mendoza, Onofre
Alharthi, Bader
Clements-Baker, Marie
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1595 - 1595
[3] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Distler, Oliver
Highland, Kristin B.
Gahlemann, Martina
Azuma, Arata
Fischer, Aryeh
Mayes, Maureen D.
Raghu, Ganesh
Sauter, Wiebke
Girard, Mannaig
Alves, Margarida
Clerisme-Beaty, Emmanuelle
Stowasser, Susanne
Tetzlaff, Kay
Kuwana, Masataka
Maher, Toby M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26): : 2518 - 2528
[4] Nintedanib for systemic sclerosis-associated interstitial lung disease
Thorley, Jennifer
[J]. LANCET RHEUMATOLOGY, 2021, 3 (11): : E755 - E755
[5] Nintedanib for systemic sclerosis-associated interstitial lung disease
Rahimi, Susan
[J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (02): : 136 - 136
[6] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease REPLY
Distler, Oliver
Gahlemann, Martina
Maher, Toby M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1596 - 1597
[7] Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis-associated interstitial lung disease
Wollin, Lutz
Distler, Joerg H. W.
Denton, Christopher P.
Gahlemann, Martina
[J]. JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2019, 4 (03) : 212 - 218
[8] Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease
Kuwana, Masataka
Azuma, Arata
[J]. MODERN RHEUMATOLOGY, 2020, 30 (02) : 225 - 231
[9] Treatment for systemic sclerosis-associated interstitial lung disease
Roofeh, David
Lescoat, Alain
Khanna, Dinesh
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
[10] Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States
Bernstein, Elana J.
Assassi, Shervin
Castelino, Flavia, V
Chung, Lorinda
Correia, Chase
Evnin, Luke B.
Frech, Tracy M.
Gordon, Jessica K.
Skaug, Brian A.
Hant, Faye N.
Hummers, Laura K.
Sandorfi, Nora
Shah, Ami A.
Shanmugam, Victoria K.
Steen, Virginia D.
Khanna, Dinesh
[J]. ACR OPEN RHEUMATOLOGY, 2022, 4 (07) : 596 - 602

← 1 2 3 4 5 →